Table 2.
The association of SPOP expression with clinicopathological features in EC.
| SPOP | ||||
|---|---|---|---|---|
| Factor | Cases | Negative | Positive | P |
| Age | ||||
| <50 | 42 | 29 | 13 | |
| ≥50 | 108 | 86 | 22 | 0.169 |
| Histological grade | ||||
| G1 | 42 | 18 | 24 | |
| G2 | 72 | 66 | 6 | |
| G3 | 36 | 31 | 5 | <0.01 |
| FIGO stage | ||||
| I+II | 89 | 60 | 25 | |
| III+IV | 61 | 55 | 10 | 0.044 |
| Muscular layer infiltration | ||||
| ≤1/2 | 79 | 53 | 26 | |
| >1/2 | 71 | 62 | 9 | 0.003 |
| Lymph node metastasis | ||||
| No | 96 | 69 | 28 | |
| Yes | 54 | 46 | 7 | 0.030 |